Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00025491
DRKS00025491
Not yet recruiting
未知

A Randomized, Experimental Evaluation Study of the Patient-Related, Medical, and Health Care Benefits of the Digital Therapy Companion TINO DTB (Therapy In Oncology Digital Therapy Companion). - TINO-DTB DiGA

DTB Gesellschaft für digitale Therapiebegleitung mbH0 sites320 target enrollmentJune 21, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC50.0C50.1C50.2C50.3C50.4C50.5C50.6C50.8C50.9C34.0C34.1C34.2C34.3C34.8C34.9C90.0Nipple and areolaCentral portion of breastUpper-inner quadrant of breastLower-inner quadrant of breastUpper-outer quadrant of breastLower-outer quadrant of breastAxillary tail of breastOverlapping lesion of breastBreast, unspecifiedMain bronchusUpper lobe, bronchus or lungMiddle lobe, bronchus or lungLower lobe, bronchus or lungOverlapping lesion of bronchus and lungBronchus or lung, unspecifiedMultiple myeloma

Overview

Phase
未知
Intervention
Not specified
Conditions
C50.0
Sponsor
DTB Gesellschaft für digitale Therapiebegleitung mbH
Enrollment
320
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
DTB Gesellschaft für digitale Therapiebegleitung mbH

Eligibility Criteria

Inclusion Criteria

  • •Any of the following oncologic indications: Malignant neoplasm of the mammary gland (BC; ICD\-10 code: C50\.\-), Malignant neoplasm of the bronchi and lungs (LC; ICD\-10 code: C34\.\-), Multiple myeloma (MM; ICD\-10 code: C90\. 0\); restart of oral systemic oncology therapy, minimum age: 18 years, signed Informed Consent (IC) at baseline, physician assessment of whether the patient is able to use the Tino DTB application.

Exclusion Criteria

  • •No oral cancer therapy. Under age.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prospective randomized study of the evaluation of the efficacy and the invasiveness in the treatment of benign prostatic hyperplasia with transurethral thulium laser surgery and transurethral resection of the prostateBenign Prostatic Hyperplasia
JPRN-UMIN000039731Tokai University school of medicine140
Completed
Not Applicable
This study assessing the efficacy and safety of Ozurdex implant alone Vs Ozurdex implant plus Laser in patient with impairment of vision due to ophthalmic illness (Macular Edema follow by Branch Retinal Vein Occlusion).
CTRI/2014/03/004508Allergan India Private Limited40
Not yet recruiting
Phase 4
Comparison of Intraperitoneal administration (giving drug into the abdominal cavity) of Ropivacaine (local anaesthetic) with Dexmedetomidine (sedative) Versus Ropivacaine with Ketamine (sedative) for Post Operative Pain Relief Following Laparoscopic Cholecystectomy
CTRI/2019/11/022129CMS and GTB Hospital
Not yet recruiting
Not Applicable
breath control yogaHealth Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
CTRI/2019/07/020004Dr Mahadev
Completed
Not Applicable
Randomized prospective study for the evaluation of the clinical long-term behavior of all-ceramic partial crowns and onlays made of VITA Suprinity®partial dental hart tissue losing
DRKS00005611VITA Zahnfabrik H. Rauter GmbH & Co. KG60